Cure Collective
Change the future for people living with Parkinson’s. Join the Cure Collective.
This is your opportunity to become part of a community united by its determination to cure Parkinson’s.
Join us and pledge to give £5,000, or more, each year for five years to our groundbreaking International Linked Clinical Trials Programme (iLCT). The iLCT programme, led in partnership by Cure Parkinson’s and Van Andel Institute (VAI), is an initiative that brings together leading Parkinson’s experts and advocates to prioritise potentially disease-modifying treatments for clinical evaluation. Many of the drugs prioritised by the iLCT Committee have been approved to treat other conditions and passed crucial safety tests, so have potential to get to the clinic much faster.
This initiative, founded by our Director of Clinical Development, Dr Richard Wyse, propels potential treatments for Parkinson’s into clinical trials to help find a cure faster.
Since 2018, the Cure Collective have raised over £900,000. This has the power to transform the lives of 11.8 million people living with Parkinson’s worldwide. Will you join us?
Why join the Cure Collective?
- You will be helping to make Parkinson’s medical history
- Gain exclusive access to the latest developments in our research
- You will be invited to exclusive in person and virtual events throughout the year
- Receive regular updates in the Cure Collective quarterly newsletter.
Meet our Co-Chairs
If you would like to find out more about the Cure Collective, please email Elizabeth using the button below.
